Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹14 Cr₹16 Cr₹11 Cr₹11 Cr₹-0.68 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?

The latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES is ₹14 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹14 Cr
Mar2025₹16 Cr
Mar2024₹11 Cr
Mar2023₹11 Cr
Mar2022₹-0.68 Cr

How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹14 Cr
-7.99
Mar2025 ₹16 Cr
42.73
Mar2024 ₹11 Cr
2.54
Mar2023 ₹11 Cr
Positive
Mar2022 ₹-0.68 Cr -

Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹2,136.8 Cr 3.9% -6.9% 202.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr -1.4% 2.4% 17.1% Stock Analytics
DIVIS LABORATORIES ₹220,946.0 Cr 12.2% 23.1% 21.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,907.0 Cr 2.4% 5.3% 41.7% Stock Analytics
CIPLA ₹118,674.0 Cr 1.7% 0.7% -3.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,648.7 Cr 3% -14.9% -10.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

3.9%

-6.9%

202.1%

SENSEX

2.4%

1.5%

-4.3%


You may also like the below Video Courses